Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 8, 2007, Pages 653-657

  Matos, Carla A L ^a   Perez, Renata M ^a   Lemos, Lara B ^a   Medina Pestana, José O ^a   Lanzoni, Valeria P ^a   Alberto, Fernando L ^b   Moreira, Eloísa S ^b   Silva, Antonio Eduardo B ^a   Ferraz, Maria Lucia G ^a,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

^c NONE   (Brazil)

Author keywords

Fibrosis; Hepatitis B; Hepatitis B virus DNA; Hepatitis C; Kidney transplantation; Liver biopsy

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; MEMBRANE ANTIGEN; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOST; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK; SEX; TIME; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 34447576814     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328133f091     Document Type: Article

References (17)

1. Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2003; 63:2222-2229.
2. Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29:257-263.
3. Fabrizi F, Martin P, Dixit V, Kanwal F, Dulai G. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005; 5:2913-2921.
4. Ridruejo E, Brunet Mdel R, Cusumano A, Diaz C, Michel MD, Jost L, et al. HBsAg as predictor of outcome in renal transplant patients. Medicina (B Aires) 2004; 64:429-432.
5. Aroldi A, Lampertico P, Montagnino G, Passerini P, Villa M, Campise MR, et al. Natural history of hepatitis B and C in renal allograft recipients. Transplantation 2005; 79:1132-1136.
6. Ribes J, Cleries R, Rubio A, Hernandez JM, Mazzara R, Madoz P, et al. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up. Int J Cancer 2006; 119:687-694.
7. Tran TT, Martin P. Hepatitis B: epidemiology and natural history. Clin Liver Dis 2004; 8:255-266.
8. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130:678-686.
9. Lau JY, Bain VG, Davies SE, O'Grady JG, Alberti A, Alexander GJ, et al. High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102:956-962.
10. Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991; 14:64-647.
11. Pace FHL, Pacheco MS, Matos CAL, Silva GA, Ferraz MLG, Perez RM, et al. Prevalence and impact of hepatitis C co-infection in patients with chronic hepatitis B virus infection. Hepatology 2002; 36:551A.
12. Moutinho RS, Perez RM, Pace FH, Ferreira AS, Cendoroglo M, Medina-Pestana JO, et al. Lack of impact of hepatitis C virus coinfection in end-stage renal disease patients with hepatitis B virus infection. Transplant Proc 2005; 37:2080-2082.
13. Wedemeyer H, Pethig K, Wagner D, Flemming P, Oppelt P, Petzold DR, et al. Long-term outcome of chronic hepatitis B in heart transplant recipients. Transplantation 1998; 66:1347-1353.
14. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999; 29:1306-1310.
15. Sheng WH, Chen MY, Hsieh SM, Hsiao CF, Wang JT, Hung CC, et al. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic. Clin Infect Dis 2004; 38:1471-147.
16. David Neto E, Americo da Fonseca J, Jota de Paula F, Nahas WC, Sabbaga E, Ianhez LE. The impact of azathioprine on chronic viral hepatitis in renal transplantation: a long-term, single-center, prospective study on azathioprine withdrawal. Transplantation 1999; 68:976-980.
17. Balal M, Demir E, Paydas S, Sertdemir Y, Erken U. Uncommon side effect of MMF in renal transplant recipients. Ren Fail 2005; 27:591-594.